News | November 18, 2024
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Copyrights are essential to the protection of original works that are fixed in a tangible medium of expression, such as a book, artwork, photograph, or music. Copyrights, a form of intellectual property, protect creative and expressive works from unauthorized copying and certain similar acts. Various types of remedies can be available in copyright litigation, including actual damages, the defendant’s profits, statutory damages, reasonable royalty damages, and injunctive relief. The determination of an appropriate remedy or remedies can involve complex economic issues including an analysis of causation (i.e., a nexus, or economic link, between the alleged conduct and economic performance), evaluation of factors that affect financial outcomes and that are unrelated to the alleged conduct, determination of the length of the loss period, identification and measurement of offsets to claimed damages, and assessment of possible future damages. Our economic, finance, accounting, and statistical experts provide robust research, analysis, and expertise to assist clients in valuing copyrights and resolving copyright disputes involving statistical modeling or claims for monetary recovery or injunctive relief.
Our analyses of copyright issues are not cookie-cutter. We tailor our approaches to the specific issues presented in each case and let relevant facts and robust analytical principles guide our work.
Because no two copyright cases are the same, we perform statistical analyses, utilize forensic accounting techniques, and employ benchmarking analytics as appropriate to generate damages models to align with case-specific issues. Our experts routinely provide analysis, opinions, and testimony in copyright disputes for both plaintiffs and defendants. Our team’s combined experience spans several industries that drive economic value, including software, movies, architectural design, medical devices, toys, music production, clothing, performance music rights, children’s streaming and television, telecommunications, software, and arts & crafts products.
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Under Dr. Guyer’s leadership, the new Engineering & Scientific Consulting practice will provide the critical research, analysis, and investigations expertise necessary to solve the challenging science, engineering, and regulatory questions behind why products fail and the implications for stakeholders.
The US Music Industries: Jobs & Benefits — 2024 Report
Robert Stoner and Jéssica Dutra have recently published The U.S. Music Industries: Jobs & Benefits—2024 Report for the Recording Industry Association of America where we measure the music industries’ economic impact nationwide, which overall contribute $212 billion to the GDP and account for 2.5 million jobs.